Silvia Lope-Piedrafita

Dr. Silvia Lope-Piedrafita

orcid

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 September 2013 in PLOS ONE
Verified
Journal Article
Open access
PDF file
ARAnna Rosell
Anna Rosell
AMAnna Morancho
Anna Morancho
MNMiriam Navarro-Sobrino
Miriam Navarro-Sobrino
EMElena Martinez-Saez
Elena Martinez-Saez
MGMar Hernandez Guillamon
Mar Hernandez Guillamon
JMJoan Montaner
Joan Montaner
Cell therapy with endothelial progenitor cells (EPCs) has emerged as a promising strategy to regenerate the brain after stroke. Here, we aimed to investigate if treatment with EPCs or their secreted factors could potentiate angiogenesis and neurogenesis after permanent focal cerebral ischemia in a mouse model of ischemic stroke. BALB/C male mice were subjected to distal occlusion of the middle cerebral artery, and EPCs, cell-free conditioned media (CM) obtained from EPCs, or vehicle media were administered one day after ischemia. Magnetic resonance imaging (MRI) was performed at baseline to confirm that the lesions were similar between groups. Immunohistochemical and histological evaluation of the brain was performed to evaluate angio-neurogenesis and neurological outcome at two weeks. CM contained growth factors, such as VEGF, FGF-b and PDGF-bb. A significant increase in capillary density was noted in the peri-infarct areas of EPC- and CM-treated animals. Bielschowsky’s staining revealed a significant increase in axonal rewiring in EPC-treated animals compared with shams, but not in CM-treated mice, in close proximity with DCX-positive migrating neuroblasts. At the functional level, post-ischemia forelimb strength was significantly improved in animals receiving EPCs or CM, but not in those receiving vehicle media. In conclusion, we demonstrate for the first time that the administration of EPC-secreted factors could become a safe and effective cell-free option to be considered in future therapeutic strategies for stroke.

17 January 2018
Verified
Book Chapter
Closed access
PDF file
SLSilvia Lope-Piedrafita
Silvia Lope-Piedrafita

1 April 2010 in Nanomedicine: Nanotechnology, Biology and Medicine
Verified
Journal Article
Closed access
Carlos Martinez-BoubetaCarlos Martinez-Boubeta
Carlos Martinez-Boubeta
LBLluis Balcells
Lluis Balcells
RCRosa Cristòfol
Rosa Cristòfol
CORAL SANFELIUCORAL SANFELIU
CORAL SANFELIU
ERElisenda Rodríguez
Elisenda Rodríguez
BMBenjamin Martínez
Benjamin Martínez

4 November 2005 in Journal of Neuroscience Research
Verified
Journal Article
Closed access
PDF file
IAIram Ahmad
Iram Ahmad
SLSilvia Lope-Piedrafita
Silvia Lope-Piedrafita
XBXiaoning Bi
Xiaoning Bi
CHChad Hicks
Chad Hicks
YYYueqin Yao
Yueqin Yao
RERobert P. Erickson
Robert P. Erickson

1 October 2012 in Journal of Molecular and Cellular Cardiology
Verified
Journal Article
Closed access
APA. Planavila
A. Planavila
EDE. Dominguez
E. Dominguez
MNM. Navarro
M. Navarro
Manlio VinciguerraManlio Vinciguerra
Manlio Vinciguerra
RIR. Iglesias
R. Iglesias
FVFrancesc Villarroya
Francesc Villarroya

27 November 2002 in Physical Review E
Verified
Journal Article
Open access
PDF file
GMGary V. Martinez
Gary V. Martinez
EDEmily M. Dykstra
Emily M. Dykstra
SLSilvia Lope-Piedrafita
Silvia Lope-Piedrafita
CJConstantin Job
Constantin Job
MBMichael F. Brown
Michael F. Brown
In solid-state 2H NMR of fluid lipid bilayers, quasielastic deformations at MHz frequencies are detected as a square-law dependence of the nuclear spin-lattice (R1Z) relaxation rates and order parameters (SCD). The signature square-law slope is found to decrease progressively with the mole fraction of cholesterol and with the acyl chain length, due to a stiffening of the membrane. The correspondence to thermal vesicle fluctuations and molecular dynamics simulations implies that a broad distribution of modes is present, ranging from the membrane size down to the molecular dimensions.